Plasma extrachromosomal circular DNA is a pathophysiological hallmark of short‐term intensive insulin therapy for type 2 diabetes

BACKGROUND: Extrachromosomal circular DNA (eccDNA) has emerged as a promising biomarker for disease diagnosis and prognosis prediction. However, its role in type 2 diabetes remains unexplored. OBJECTIVE: To investigate the characteristics and dynamics of circulating eccDNAs in newly diagnosed type 2...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Zhe, He, Junyu, Han, Peng, Dai, Peiji, Lv, Wei, Liu, Nian, Liu, Liyi, Liu, Liehua, Pan, Xiaoguang, Xiang, Xi, Li, Hanbo, Ge, Fangfang, Gao, Shan, Liao, Zhihong, Luo, Yonglun, Li, Yanbing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10587738/
https://www.ncbi.nlm.nih.gov/pubmed/37859516
http://dx.doi.org/10.1002/ctm2.1437

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10587738/
https://www.ncbi.nlm.nih.gov/pubmed/37859516
http://dx.doi.org/10.1002/ctm2.1437

Ejemplares similares